Get started
Author

April L Studinski Jones

Observed name: April L. Studinski Jones
Institution: Mayo Clinic
Observed institution: Mayo Clinic
ORCID: 0009-0009-9356-8669
Observed ORCID: 0009-0009-9356-8669
OpenAlex ID: A5017678450
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project
2011 · David M.S. McHugh, Cynthia A. Cameron, et al. · Genetics in Medicine · 355
PDF
De novo 11q deletion including SHANK2 in a patient with global developmental delay
2017 · Cherisse A. Marcou, April L. Studinski Jones, et al. · American Journal of Medical Genetics Part A · 9
Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe disease
2025 · Ibrahim T. Khoja, Dawn S. Peck, et al. · Genetics in Medicine · 3
Clinical utility of untargeted urine oligosaccharide screening
2025 · Gisele Bentz Pino, Marie A. Quade, et al. · Molecular Genetics and Metabolism · 1
The Laboratory Genetic Counselor as an Educator
2017 · Eric Rosenthal, April L. Studinski Jones · Oxford University Press eBooks
Works count: 5
Citation count: 368
H-index: 3
I10-index: 1
Year
Topic
Type